We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$363M
AUM Growth
+$27.4M
Cap. Flow
-$3.13M
Cap. Flow %
-0.86%
Top 10 Hldgs %
32.22%
Holding
170
New
6
Increased
42
Reduced
67
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.23M
2
MRK icon
Merck
MRK
+$745K
3
MPC icon
Marathon Petroleum
MPC
+$515K
4
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$429K
5
INCY icon
Incyte
INCY
+$419K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.54M
2
DE icon
Deere & Co
DE
+$1.16M
3
DD icon
DuPont de Nemours
DD
+$631K
4
ABBV icon
AbbVie
ABBV
+$602K
5
OLED icon
Universal Display
OLED
+$566K

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Healthcare 16.9%
3 Industrials 15.75%
4 Consumer Staples 8.05%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHE icon
151
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$231K 0.06%
+8,450
New +$223K
EPD icon
152
Enterprise Products Partners
EPD
$82.3B
$226K 0.06%
8,030
– –
QEP
153
DELISTED
QEP RESOURCES, INC.
QEP
$225K 0.06%
50,000
-34,032
-40% -$119K
AXP icon
154
American Express
AXP
$227B
$222K 0.06%
1,789
– –
DEM icon
155
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
$220K 0.06%
+4,811
New +$209K
AGG icon
156
iShares Core US Aggregate Bond ETF
AGG
$137B
$209K 0.06%
1,861
– –
FPE icon
157
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$203K 0.06%
10,116
-44
-0.4% -$876
GLD icon
158
SPDR Gold Trust
GLD
$131B
$200K 0.06%
+1,400
New +$196K
ET icon
159
Energy Transfer Partners
ET
$70.1B
$185K 0.05%
14,437
– –
BMY.RT
160
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$76K 0.02%
+25,545
New +$66.4K
ANET icon
161
Arista Networks
ANET
$227B
– –
-16,000
Closed -$238K
UA icon
162
Under Armour Class C
UA
$2.77B
– –
-10,900
Closed -$197K
BUD
163
DELISTED
ANHEUSER BUSCH COS INC
BUD
– –
-4,300
Closed -$409K
CELG
164
DELISTED
Celgene Corp
CELG
– –
-25,545
Closed -$2.54M
3 4 5 6
7

Similar funds

VCM
Virtue Capital Management Brentwood, Tennessee $657M AUM 24.18% 1-Year Est. Return
PIM
Parker Investment Management Menlo Park, California $659M AUM 52.52% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
BL
BWCP LP Dallas, Texas $656M AUM 41.58% 1-Year Est. Return
DAS
Diversify Advisory Services Sandy, Utah $655M AUM 24.57% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return

Mengis Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Mengis Capital Management held 170 positions worth $363M, up 8.2% from $336M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Mengis Capital Management's Q4 2019 filing shows 6 new, 42 increased, 67 reduced and 4 closed positions. Its largest new stake was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K. The largest sale was Celgene Corp, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Mengis Capital Management's largest Q4 2019 buy was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K.
  • Mengis Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.23M increase.
  • Mengis Capital Management's biggest Q4 2019 reduction was Deere & Co, cutting an estimated $1.16M.
  • Mengis Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $2.54M.
  • Mengis Capital Management's ten largest holdings make up 32% of its $363M portfolio in Q4 2019.
  • Mengis Capital Management opened 6 new positions and closed 4 in Q4 2019.
  • Mengis Capital Management's portfolio value rose 8.2% quarter-over-quarter to $363M.

Based on Mengis Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.